← Back to Search

Irrisept for Cervical Spondylosis (Irrisept Trial)

Phase 4

Waitlist Available

Led By Don Kim Moore, MD

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days after surgery

Awards & highlights

Irrisept Trial Summary

This trial is testing whether using a different solution to clean wounds after surgery can help reduce complications.

Eligible Conditions

Lumbar Spine Degeneration
Cervical Spondylosis

Irrisept Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days after surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days after surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Center for Disease Control (CDC)-defined 90-day surgical site infection incidence

Secondary outcome measures

Wound complications

Wound healing

Irrisept Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: IrriseptActive Control1 Intervention

Patients in this group will be given the study drug (Irrisept).

Group II: Placebo GroupPlacebo Group1 Intervention

Patients in this group will be given the placebo (sterile saline).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor

361 Previous Clinical Trials

627,994 Total Patients Enrolled

Don Kim Moore, MDPrincipal InvestigatorUniversity of Missouri - Missouri Orthopaedic Institute

1 Previous Clinical Trials

200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently enrolling participants for this experiment?

"According to the details found on clinicaltrials.gov, this trial is no longer open for recruitment. The initial posting was made July 1st 2022 and was last updated June 17th of the same year. Currently there are 8 other studies actively recruiting patients interested in participating in a medical trial."

Answered by AI

Has Irrisept received governmental authorization for commercial distribution?

"There is ample clinical evidence to verify the security of Irrisept, thus it has earned a rating of 3 on our scale. This treatment was approved in Phase 4 trials and can be administered with confidence."

Answered by AI

Recent research and studies

Frontiers in MedicineJournal

Surgical Site Infections Following Spine Surgery: Eliminating the Controversies in the Diagnosis

Chahoud, Jad, Zeina Kanafani, and Souha S. Kanj. 2014. “Surgical Site Infections Following Spine Surgery: Eliminating the Controversies in the Diagnosis”. Frontiers in Medicine. Frontiers Media SA. doi:10.3389/fmed.2014.00007.

Journal of Neurosurgery: SpineJournal

Risk Factors for Surgical Site Infection Following Spine Surgery: Efficacy of Intraoperative Saline Irrigation

Watanabe, Masahiko, Daisuke Sakai, Daisuke Matsuyama, Yukihiro Yamamoto, Masato Sato, and Joji Mochida. 2010. “Risk Factors for Surgical Site Infection Following Spine Surgery: Efficacy of Intraoperative Saline Irrigation”. Journal of Neurosurgery: Spine. Journal of Neurosurgery Publishing Group (JNSPG). doi:10.3171/2009.11.spine09308.

Advances in OrthopedicsJournal

Intraoperative Disinfection by Pulse Irrigation with Povidone-iodine Solution in Spine Surgery

De Luna, Vincenzo, Federico Mancini, Fernando De Maio, Gabriele Bernardi, Ernesto Ippolito, and Roberto Caterini. 2017. “Intraoperative Disinfection by Pulse Irrigation with Povidone-iodine Solution in Spine Surgery”. Advances in Orthopedics. Hindawi Limited. doi:10.1155/2017/7218918.

Journal of Orthopaedic TraumaJournal